Evaluation of antibiotic stewardship among near-term and term infants admitted to a neonatal unit

• Published in: European journal of pediatrics Vol. 182; no. 1; pp. 245 - 254
• Main Authors: Feng, Kun, He, Yunyan, Liu, Weiqin, Zhang, Xinyin, Song, Ping, Hua, Ziyu
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.01.2023; Springer Nature B.V
• Subjects: Anti-Bacterial Agents - therapeutic use; Antibiotics; Antimicrobial Stewardship; Enterocolitis; Enterocolitis, Necrotizing - chemically induced; Humans; Infant; Infant, Newborn; Infections; Intervention; Medicine; Medicine & Public Health; Multidrug resistance; Multidrug resistant organisms; Necrotizing enterocolitis; Neonatal Sepsis - drug therapy; Neonates; Newborn babies; Pediatrics; Pneumonia; Retrospective Studies; Safety; Sepsis; Sepsis - drug therapy; China; Interrupted time series analysis; Quality improvement; Neonate; Antibiotic stewardship
• ISSN: 1432-1076; 0340-6199; 1432-1076
• DOI: 10.1007/s00431-022-04668-5

To evaluate the safety and effectiveness of evidence-based antibiotic stewardship in a neonatal unit in China. The study period consisted of two phases, one retrospective (the baseline period, January to December 2018, and the transition period, January 2019 to August 2020) and one prospective intervention period (September 2020 to August 2021). During the prospective period, evidence-based antibiotic stewardship was applied to neonates with suspected infections, pneumonia, and culture-negative sepsis. The antibiotic stewardship included the observation form of neonatal infections, antibiotic therapy of no more than 48 h for suspected infections, and 5 days for pneumonia and culture-negative sepsis. The change in antibiotic use measured by days of therapy per 1000 patient-days between the baseline and intervention period was analyzed. Safety outcomes included reinitiation of antibiotics within 14 days, length of stay, occurrence of late-onset sepsis and necrotizing enterocolitis (Bell stage ≥ II), multidrug-resistant organism infections, and mortality. A total of 7705 neonates were enrolled during the baseline ( n  = 4804) and the intervention periods ( n  = 2901). The total antibiotic usage during the baseline period was 771 days of therapy per 1000 patient-days, while that was 525 days of therapy per 1000 patient-days during the intervention period, indicating a 32% decrease in antibiotic consumption. No significant difference in safety outcomes was observed between the baseline and intervention period ( P  > 0.05), whereas the length of stay was longer during the intervention period ( P  < 0.001). Conclusion : The evidence-based antibiotic stewardship can safely and effectively reduce antibiotic use and shorten the duration of therapy in the neonatal unit. What is Known: • Overuse of antibiotics has been associated with adverse events in neonates, including necrotizing enterocolitis, multidrug-resistant organism infections, and death. • More clinical effectiveness evidence is needed to support antibiotic stewardship of neonates in China. What is New: • Using prospective audit, targeted stewardship interventions, this study shows that a 32% reduction in overall antibiotic consumption was achieved safely. • Implementation of evidence-based neonatal antibiotic stewardship, including the observation form of neonatal infections, antibiotic therapy of no more than 48 h for suspected infections, and 5 days for pneumonia and culture-negative sepsis, is safe and effective among newborns in a developing country.